Cargando…
Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats
This study was designed to assess whether the protective effects of bone marrow-derived mesenchymal stem cells (MSCs) against diabetes could be enhanced by pioglitazone (PIO), a PPARγ agonist. Combined MSCs and PIO treatments markedly improved fasting blood glucose, body weight, lipid profile levels...
Autores principales: | Hamza, Alaaeldin Ahmed, Fikry, Ebtehal Mohammad, Abdallah, Wedad, Amin, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026169/ https://www.ncbi.nlm.nih.gov/pubmed/29959408 http://dx.doi.org/10.1038/s41598-018-28029-1 |
Ejemplares similares
-
Combinatory Effect and Modes of Action of Chrysin and Bone Marrow-Derived Mesenchymal Stem Cells on Streptozotocin/Nicotinamide-Induced Diabetic Rats
por: Sayed, Hesham M., et al.
Publicado: (2022) -
Mechanistic Insights into Binding of Ligands with Thiazolidinedione Warhead to Human Histone Deacetylase 4
por: Schweipert, Markus, et al.
Publicado: (2021) -
Thiazolidinediones and bone fractures
por: Kaku, Kohei, et al.
Publicado: (2011) -
Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones
por: Benova, Andrea, et al.
Publicado: (2022) -
Increased Circulating Adiponectin in Response to Thiazolidinediones: Investigating the Role of Bone Marrow Adipose Tissue
por: Sulston, Richard J., et al.
Publicado: (2016)